Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Axcella Health stock price, quote, forecast and news

AXLA
US05454B1052
A2PJCG

Price

0
Today +/-
-0
Today %
-0 %
P

Axcella Health stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Axcella Health stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Axcella Health stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Axcella Health stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Axcella Health's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Axcella Health Stock Price History

DateAxcella Health Price
12/29/20230 undefined
12/28/20230 undefined

Axcella Health Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Axcella Health, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Axcella Health from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Axcella Health’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Axcella Health. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Axcella Health’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Axcella Health’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Axcella Health’s growth potential.

Axcella Health Revenue, EBIT and net profit per share

DateAxcella Health RevenueAxcella Health EBITAxcella Health Net Income
2028e0 undefined0 undefined0 undefined
2027e0 undefined0 undefined0 undefined
2026e0 undefined0 undefined0 undefined
2025e0 undefined0 undefined0 undefined
2024e0 undefined0 undefined0 undefined
2023e0 undefined0 undefined0 undefined
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined

Axcella Health Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2017201820192020202120222023e2024e2025e2026e2027e2028e
0000000000623
-----------283.33
------------
00000-23000000
-28-33-57-53-61-72-15-15-16-71-103-102
-----------1,716.67-443.48
-30-36-59-56-64-81-15-15-15-66-92-89
-20.0063.89-5.0814.2926.56-81.48--340.0039.39-3.26
0.920.180.671.271.522.17000000
------------
Details

Keystats

ⓘ

Revenue and Growth

The Axcella Health Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Axcella Health is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (k)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
201720182019202020212022
           
46.879.592.1107.35517.1
000000
000000
000000
0.30.81.51.71.60.9
47.180.393.610956.618
1.51.10.60.40.90.7
000000
000000
000000
000000
200500200200200200
1.71.60.80.61.10.9
48.881.994.4109.657.718.9
           
138.8197.80000.1
4.67.3276.3348359.3422.5
-121-157-216.1-272.6-337.2-418.4
0000-0.10
000000
22.448.160.275.4224.2
11.622.34.34.7
4.15.36.45.55.69.2
0000200200
000000
000000
5.16.98.47.810.114.1
2024.924.925.225.10
000000
1.31.90.91.20.50.6
21.326.825.826.425.60.6
26.433.734.234.235.714.7
48.881.894.4109.657.718.9
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Axcella Health provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Axcella Health's financial health and stability.

Assets

Axcella Health's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Axcella Health must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Axcella Health after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Axcella Health's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (k)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201720182019202020212022
-30-36-59-56-64-81
1,0001,0000000
000000
111023
136778
222222
000000
-26-30-50-49-54-69
-100000
000-36330
000-35331
000000
06000-20
25586465553
25636365332
---1.00--1.00-1.00
000000
-23212-20-48-6
-27.95-31.37-51.1-50.01-54.5-70.02
000000

Axcella Health stock margins

The Axcella Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Axcella Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Axcella Health.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Axcella Health's sales revenue. A higher gross margin percentage indicates that the Axcella Health retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Axcella Health's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Axcella Health's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Axcella Health's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Axcella Health. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Axcella Health's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Axcella Health Margin History

Axcella Health Gross marginAxcella Health Profit marginAxcella Health EBIT marginAxcella Health Profit margin
2028e0 %0 %0 %
2027e0 %0 %0 %
2026e0 %0 %0 %
2025e0 %0 %0 %
2024e0 %0 %0 %
2023e0 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %

Axcella Health Stock Sales Revenue, EBIT, Earnings per Share

The Axcella Health earnings per share therefore indicates how much revenue Axcella Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Axcella Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Axcella Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Axcella Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Axcella Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Axcella Health Revenue, EBIT and net profit per share

DateAxcella Health Sales per ShareAxcella Health EBIT per shareAxcella Health Earnings per Share
2028e0 undefined0 undefined0 undefined
2027e0 undefined0 undefined0 undefined
2026e0 undefined0 undefined0 undefined
2025e0 undefined0 undefined0 undefined
2024e0 undefined0 undefined0 undefined
2023e0 undefined0 undefined0 undefined
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined

Axcella Health business model

Axcella Health is a US biotechnology company focused on the development and commercialization of therapeutics based on metabolites and proteins. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts. The company utilizes the insights of metabolomics in research to enable the development of new therapeutic approaches. Its business model is based on an extensive pipeline of product candidates based on the use of metabolites. Axcella Health aims to develop new treatment methods for diseases such as liver diseases, metabolic disorders, oncology, and immunology. The company has developed products for hepatology, metabolism, and oncology. It also conducts research and development in clinical nutrition and sports medicine. Its products have the potential to revolutionize the treatment of chronic diseases and improve people's health worldwide. Axcella Health is one of the most popular companies on Eulerpool.com.

Axcella Health SWOT Analysis

Strengths

One of the primary strengths of Axcella Health Inc is its innovative and unique approach to healthcare. The company specializes in the development of novel therapeutic products that leverage the power of endogenous metabolic modulators to address various metabolic dysfunctions and disorders.

Axcella Health Inc possesses a robust pipeline of potential products that have shown promising results in preclinical and clinical studies. This strong portfolio positions the company for future growth and success.

The company's research and development capabilities are another notable strength. Axcella Health Inc has a skilled team of scientists and researchers dedicated to discovering and advancing novel therapeutic candidates.

Weaknesses

One weakness for Axcella Health Inc is its heavy reliance on the success of its ongoing clinical trials and the regulatory approval process. Any delays or negative outcomes in these areas could significantly impact the company's financial performance and reputation.

Another weakness is the potential competition from larger pharmaceutical companies. While Axcella Health Inc has built a strong pipeline, it may face challenges in gaining market share and competing with well-established players in the industry.

Opportunities

Axcella Health Inc has ample opportunities for growth and expansion. The increasing prevalence of metabolic disorders and the growing demand for innovative treatments present a favorable market environment for the company.

Collaborations and partnerships offer another avenue for Axcella Health Inc to leverage external expertise and resources. Strategic collaborations with academic institutions, research organizations, and larger pharmaceutical companies can provide access to additional funding, expertise, and potential distribution channels.

Threats

A significant threat to Axcella Health Inc is the strict regulatory environment governing the approval and commercialization of new therapeutics. The company must navigate complex regulatory pathways, which can be time-consuming and costly.

The volatility of financial markets and uncertain economic conditions can also pose threats. Axcella Health Inc may face challenges in securing adequate funding for its research and development activities or suffer from reduced patient access to healthcare due to economic pressures.

Lastly, any advancements or breakthroughs by competitors in similar therapeutic areas can pose a threat to Axcella Health Inc's market position and potential revenue streams.

Axcella Health Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Axcella Health historical P/E ratio, EBIT, and P/S ratio.

Axcella Health shares outstanding

The number of shares was Axcella Health in 2023 — This indicates how many shares 2.17 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Axcella Health earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Axcella Health's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Axcella Health’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Axcella Health's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Axcella Health Stock splits

In Axcella Health's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Axcella Health.

Axcella Health latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20230 0  (18.3 %)2023 Q2
3/31/20230 0  (69.36 %)2023 Q1
12/31/20220 0  (-7.84 %)2022 Q4
9/30/20220 0  (12.66 %)2022 Q3
6/30/20220 0  (-3.2 %)2022 Q2
3/31/20220 0  (-15.64 %)2022 Q1
12/31/20210 0  (-0.86 %)2021 Q4
9/30/20210 0  (12.24 %)2021 Q3
6/30/20210 0  (3.74 %)2021 Q2
3/31/20210 0  (5.88 %)2021 Q1
1
2

Eulerpool ESG Scorecard© for the Axcella Health stock

Eulerpool World ESG Rating (EESG©)

38/ 100

🌱 Environment

41

👫 Social

42

🏛️ Governance

32

Environment

Scope 1 - Direct Emissions
—
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
—
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
✅
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
❌

Social

Percentage of female employees49
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety❌
Catholic✅

Governance (Corporate Governance)

Environmental reporting❌
Stakeholder Engagement❌
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Axcella Health list of shareholders

%
Name
Stocks
Change
Date
8.41753 % HarbourVest Partners, L.L.C.248,31706/30/2023
4.00776 % Fidelity Management & Research Company LLC118,229-292,6738/31/2023
39.66312 % Flagship Ventures1,170,06206/30/2023
15.05824 % Nestle Health Science US Holdings, Inc.444,218146,34212/31/2022
1.11651 % The Vanguard Group, Inc.32,93706/30/2023
0.45875 % Geode Capital Management, L.L.C.13,53306/30/2023
0.33580 % BlackRock Institutional Trust Company, N.A.9,906-1,9036/30/2023
0.28441 % Epstein (David R)8,3901,8825/19/2022
0.27173 % Bridgeway Capital Management, LLC8,01606/30/2023
0.13559 % Edgewood Management LLC4,00006/30/2023
1
2
3
4
5
...
8

Axcella Health Executives and Management Board

Mr. William Hinshaw54
Axcella Health President, Chief Executive Officer, Director (since 2018)
Compensation 1.31 M
Dr. Paul Fehlner59
Axcella Health Senior Vice President, Chief Legal Officer and Corporate Secretary
Compensation 644,175
Dr. Michael Rosenblatt75
Axcella Health Independent Director
Compensation 97,353
Dr. Martin Hendrix55
Axcella Health Independent Director
Compensation 93,864
Mr. William Baird51
Axcella Health Independent Director (since 2020)
Compensation 93,452
1
2
3

Most common questions regarding Axcella Health

What values and corporate philosophy does Axcella Health represent?

Axcella Health Inc represents a strong commitment to improving human health through innovative science and research. The company's corporate philosophy revolves around harnessing the power of endogenous metabolic modulators, known as EMMs, to address various metabolic dysregulation conditions. Axcella Health Inc is dedicated to advancing the understanding and utilization of EMMs to develop transformative therapeutics. By leveraging its proprietary platform, this cutting-edge company aims to revolutionize the treatment of complex diseases and enhance overall wellness. With a focus on scientific rigor and clinical evidence, Axcella Health Inc strives to bring novel and effective solutions to patients worldwide.

In which countries and regions is Axcella Health primarily present?

Axcella Health Inc is primarily present in the United States.

What significant milestones has the company Axcella Health achieved?

Axcella Health Inc has achieved significant milestones since its inception. Some notable achievements include successfully completing its initial public offering (IPO) in 2019, which raised substantial funding for the company's research and development efforts. Additionally, Axcella Health Inc has made remarkable progress in advancing its innovative pipeline of Multi-Targeted Non-Bioengineered (MTNB) therapeutic candidates. The company has also expanded its collaborative partnerships and collaborations with leading research institutions and organizations. These achievements demonstrate Axcella Health Inc's commitment to revolutionizing therapeutic approaches and advancing the treatment of complex diseases.

What is the history and background of the company Axcella Health?

Axcella Health Inc is a biotechnology company that specializes in developing transformative therapies to improve the lives of patients. Founded in 2009, the company is focused on harnessing the power of endogenous metabolic modulators (EMMs) to address various diseases and disorders. Axcella Health Inc's innovative approach involves leveraging the body's natural metabolic pathways to restore health and function. With a commitment to scientific rigor and cutting-edge research, the company aims to bring novel treatment options to patients in need. Axcella Health Inc continues to advance its pipeline of potential therapies and collaborate with partners to accelerate the development and commercialization of its groundbreaking solutions.

Who are the main competitors of Axcella Health in the market?

The main competitors of Axcella Health Inc in the market include companies like Intercept Pharmaceuticals Inc, Madrigal Pharmaceuticals Inc, and Viking Therapeutics Inc.

In which industries is Axcella Health primarily active?

Axcella Health Inc is primarily active in the biotechnology industry.

What is the business model of Axcella Health?

The business model of Axcella Health Inc revolves around developing and commercializing novel therapeutic products. Based in the United States, Axcella Health focuses on utilizing the potential of endogenous metabolic modulators (EMMs) to target various biological pathways and address complex diseases. By harnessing the power of EMMs, Axcella Health aims to provide innovative solutions for conditions like liver and muscle disorders, oncology, and metabolic diseases. With a keen focus on research and development, Axcella Health strives to bring forth transformative treatments that can improve patients' lives and contribute to the advancement of medical science.

What is the P/E ratio of Axcella Health 2024?

The P/E ratio cannot be calculated for Axcella Health at the moment.

What is the P/S ratio of Axcella Health 2024?

The P/S cannot be calculated for Axcella Health currently.

What is the AlleAktien quality score of Axcella Health?

The AlleAktien quality score for Axcella Health is 2/10.

What is the revenue of Axcella Health 2024?

The revenue cannot currently be calculated for Axcella Health.

How high is the profit of Axcella Health 2024?

The profit cannot currently be calculated for Axcella Health.

What is the business model of Axcella Health

Axcella Health Inc is a biopharmaceutical company focused on the development of novel, multifunctional drugs. The company has developed a proprietary platform called "axcellerator" that allows it to identify and screen potential drug candidates on a large scale. Axcella Health's business model is primarily focused on licensing its drug candidate identification platform to biotechnology and pharmaceutical companies. The company has also developed its own pipeline of products that it markets itself. Axcella Health targets companies that are in search of new drug candidates and want to accelerate their own research and development. Axcella Health's platform provides these companies with a fast and cost-effective method for identifying drug candidates on a large scale. By utilizing "axcellerator," Axcella Health can quickly identify a large number of potential drugs and then test and screen them for efficacy and safety. Axcella Health has also developed a range of products based on this platform. The products primarily operate in the areas of metabolic health and immunology. These products are all patented and provide the company the opportunity to test its platform in practice while generating revenue through licensing and sales. Axcella Health is currently developing several products, including: - AXA1125: A potential candidate for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). - AXA1957: A potential candidate for the treatment of type 2 diabetes and insulin-dependent diabetes. - AXA2678: A potential candidate for the treatment of cancer and autoimmune diseases. Axcella Health has also partnered with Nestle Health Science to jointly develop new products in the field of metabolic health. Overall, Axcella Health's business model is focused on leveraging the power of its platform and its own expertise in drug research and development to help companies and products worldwide. This model allows Axcella Health to develop a wide range of products while generating revenue, making it a compelling business model for investors and partners.

What is the Axcella Health dividend?

Axcella Health pays a dividend of 0 USD distributed over payouts per year.

How often does Axcella Health pay dividends?

The dividend cannot currently be calculated for Axcella Health or the company does not pay out a dividend.

What is the Axcella Health ISIN?

The ISIN of Axcella Health is US05454B1052.

What is the Axcella Health WKN?

The WKN of Axcella Health is A2PJCG.

What is the Axcella Health ticker?

The ticker of Axcella Health is AXLA.

How much dividend does Axcella Health pay?

Over the past 12 months, Axcella Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Axcella Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Axcella Health?

The current dividend yield of Axcella Health is .

When does Axcella Health pay dividends?

Axcella Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Axcella Health?

Axcella Health paid dividends every year for the past 0 years.

What is the dividend of Axcella Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Axcella Health located?

Axcella Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Axcella Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Axcella Health from 9/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Axcella Health pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of Axcella Health in the year 2023?

In the year 2023, Axcella Health distributed 0 USD as dividends.

In which currency does Axcella Health pay out the dividend?

The dividends of Axcella Health are distributed in USD.

All fundamentals about Axcella Health

Our stock analysis for Axcella Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Axcella Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.